Encompass Health (AMEX:EHC)‘s stock had its “buy” rating reaffirmed by equities research analysts at Stephens in a research note issued on Friday. They currently have a $55.00 price target on the stock. Stephens’ target price points to a potential upside of 6.88% from the company’s previous close.
EHC has been the subject of a number of other research reports. SunTrust Banks set a $58.00 target price on shares of Encompass Health and gave the stock a “buy” rating in a report on Thursday, December 21st. Zacks Investment Research raised shares of Encompass Health from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Royal Bank of Canada reaffirmed a “buy” rating on shares of Encompass Health in a report on Wednesday, November 15th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Tuesday, November 21st. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and set a $50.00 target price on shares of Encompass Health in a report on Sunday, September 17th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $53.11.
Shares of Encompass Health (AMEX:EHC) opened at $51.46 on Friday. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health has a fifty-two week low of $38.24 and a fifty-two week high of $52.58. The company has a market cap of $4,960.00, a price-to-earnings ratio of 18.78, a price-to-earnings-growth ratio of 1.70 and a beta of 0.54.
Encompass Health (AMEX:EHC) last released its earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The firm had revenue of $995.60 million during the quarter, compared to analyst estimates of $985.75 million. During the same quarter in the previous year, the business earned $0.65 EPS. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. equities analysts forecast that Encompass Health will post 2.72 earnings per share for the current fiscal year.
In other news, Director Yvonne M. Curl purchased 1,000 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was bought at an average price of $45.95 per share, with a total value of $45,950.00. Following the acquisition, the director now directly owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is owned by insiders.
An institutional investor recently bought a new position in Encompass Health stock. Nisa Investment Advisors LLC purchased a new stake in Encompass Health Corp (AMEX:EHC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 23,420 shares of the company’s stock, valued at approximately $1,157,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/01/14/encompass-health-ehc-stock-rating-reaffirmed-by-stephens.html.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.